4//SEC Filing
Rangwala Reshma 4
Accession 0000950170-24-023297
CIK 0001503802other
Filed
Feb 28, 7:00 PM ET
Accepted
Feb 29, 5:36 PM ET
Size
4.9 KB
Accession
0000950170-24-023297
Insider Transaction Report
Form 4
Rangwala Reshma
EVP & Chief Medical Officer
Transactions
- Award
Common Stock
2024-02-28+198,959→ 371,356 total
Footnotes (1)
- [F1]Represents the award of restricted stock units ("RSUs") pursuant to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan, as amended. RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest in three equal annual installments beginning February 28, 2025.
Documents
Issuer
Karyopharm Therapeutics Inc.
CIK 0001503802
Entity typeother
Related Parties
1- filerCIK 0001825322
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Feb 29, 5:36 PM ET
- Size
- 4.9 KB